Dimeric Fcγ Receptor Enzyme-Linked Immunosorbent Assay To Study HIV-Specific Antibodies: A New Look into Breadth of Fcγ Receptor Antibodies Induced by the RV144 Vaccine Trial.

Saved in:
Bibliographic Details
Title: Dimeric Fcγ Receptor Enzyme-Linked Immunosorbent Assay To Study HIV-Specific Antibodies: A New Look into Breadth of Fcγ Receptor Antibodies Induced by the RV144 Vaccine Trial.
Authors: McLean MR; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Melbourne, Victoria 3000, Australia., Madhavi V; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Melbourne, Victoria 3000, Australia., Wines BD; Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria 3004, Australia.; Department of Immunology, Monash University Central Clinical School, Melbourne, Victoria 3004, Australia.; Department of Pathology, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia., Hogarth PM; Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria 3004, Australia.; Department of Immunology, Monash University Central Clinical School, Melbourne, Victoria 3004, Australia.; Department of Pathology, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia., Chung AW; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Melbourne, Victoria 3000, Australia; skent@unimelb.edu.au awchung@unimelb.edu.au., Kent SJ; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Melbourne, Victoria 3000, Australia; skent@unimelb.edu.au awchung@unimelb.edu.au.; Melbourne Sexual Health Centre, Infectious Diseases Department, Alfred Health, Monash University Central Clinical School, Melbourne, Victoria 3053, Australia; and.; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia.
Source: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2017 Jul 15; Vol. 199 (2), pp. 816-826. Date of Electronic Publication: 2017 Jun 14.
Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1550-6606
DOI:10.4049/jimmunol.1602161